Clinical trial Recruiting at 7 sites Observational Ages 18 to 50

Impact of cancer treatments on reproductive and sexual health in young colorectal cancer patients

Official title: The Effects of Chemotherapy or Radiotherapy on Reproductive and Sexual Health of Early Onset Colorectal Cancer Patients

Run by Memorial Sloan Kettering Cancer Center · NCT04812912 · Data updated 2026-11-12

This study looks at how chemotherapy and radiation therapy affect the reproductive and sexual health of young people with early onset colorectal cancer.

More Colorectal Cancer trials

Quick facts

Study typeObservational
Ages18 Years to 50 Years
SexAll
Enrollment120 (estimated)
SponsorMemorial Sloan Kettering Cancer Center
Academic / other
Drugs / interventionschemotherapy, radiation
Locations7 sites (Basking Ridge, New Jersey and 6 other locations)
StatusRecruiting
StartedMarch 18, 2021
Main results expectedMarch 18, 2027
Study endsMarch 18, 2027
Registry record updatedApril 7, 2026
Trial IDNCT04812912 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 18-40 years who are premenopausal females or 18-50 years for males, diagnosed with colorectal adenocarcinoma and eligible for curative therapy.

Probably not a fit

Patients with prior systemic treatment for colorectal cancer or those with active secondary malignancies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate how chemotherapy and radiation therapy affect reproductive and sexual health in individuals diagnosed with early onset colorectal cancer. Researchers will monitor changes in hormone levels and assess sexual and reproductive health through questionnaires. The goal is to gather valuable information that can enhance understanding of the implications of cancer treatments on fertility and overall quality of life for these patients.

Why it matters

Potential benefit: If successful, this study could provide insights that help improve reproductive health management for young colorectal cancer patients undergoing treatment.

How similar studies have gone: While there is ongoing research in the area of cancer treatment effects on reproductive health, this specific focus on early onset colorectal cancer is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18-40 years of age and premenopausal (female) or 18-50 years of age (male) at time of diagnosis
* Histologic diagnosis of colorectal adenocarcinoma
* Able and willing to participate in the informed consent process
* Eligible for curative adjuvant or neoadjuvant therapy for colon or rectal cancer
* Willing and able to complete protocol questionnaires
* Rectal patients only: Individuals who will be receiving chemotherapy, followed by chemoradiotherapy (ChemoRT)

Exclusion Criteria:

* Prior systemic treatment for this malignancy
* Active or prior secondary malignancy
* History of ovarian resection (if female)
* Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception until the termination of gestation, confirmed by a positive hCG laboratory test.

Where it's running

  • Memorial Sloan Kettering Basking Ridge
    Basking Ridge, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Monmouth
    Middletown, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Bergen
    Montvale, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Cancer Center at Suffolk - Commack
    Commack, New York, United States
    Recruiting
  • Memorial Sloan Kettering Westchester
    Harrison, New York, United States
    Recruiting
  • Memorial Sloan Kettering Cancer Center
    New York, New York, United States
    Recruiting
Show 1 more location
  • Memorial Sloan Kettering Nassau
    Rockville Centre, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Andrea Cercek, MD — Memorial Sloan Kettering Cancer Center
  • Study coordinator: Andrea Cercek, MD
  • Email: cerceka@mskcc.org
  • Phone: 646-888-4189

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.